| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2025―Dec―07 |
Hydroxychloroquine does not affect endotheliopathy or coagulopathy biomarkers in COVID-19: longitudinal results from the DisCoVeRy randomized trial |
Clément R. Massonnaud, Maya Hites, Nathan Peiffer-Smadja, Jeanne Rancic, Yazdan Yazdanpanah, Sophie Luneau, Annabelle Dupont, Christelle Delmas, Jean-Luc Diehl, Aurélien Philippe, Sophie Susen, France Mentré, Florence Ader, David M. Smadja |
| 2 |
[GO] |
2024―Dec―20 |
Circulating endothelial cells: a key biomarker of persistent fatigue after hospitalization for COVID-19 |
David M. Smadja, Sven Günther, Pauline Cavagna, Bertrand Renaud, Dominique Salmon, Bertrand Hermann, Brigitte Ranque, Cédric Lemogne, Jean-Luc Diehl, Aurélien Philippe |
| 3 |
[GO] |
2024―Apr―24 |
Systemic glucocorticoids link to long-term microvascular injury in COVID-19 |
Qian Yang, Cai Yun Xia, Ying Cai, Yan Fang Zhang, Dao Ting Li, Shu Qi Wu, Peng Hu |
| 4 |
[GO] |
2024―Apr―10 |
Interleukin-6 drives endothelial glycocalyx damage in COVID-19 and bacterial sepsis |
Carolin Christina Drost, Alexandros Rovas, Irina Osiaevi, Klaus Schughart, Alexander Lukasz, Wolfgang A. Linke, Hermann Pavenstädt, Philipp Kümpers |
| 5 |
[GO] |
2024―Mar―26 |
Connective tissue disorders in COVID-19: Reply to “People with a connective tissue disorder may be especially vulnerable to the endothelial damage that characterizes long COVID due to the fragility of their vasculature and slow wound healing” |
Xiaoming Wu, Valerie A. Novakovic, Jialan Shi |
| 6 |
[GO] |
2024―Feb―06 |
People with a connective tissue disorder may be especially vulnerable to the endothelial damage that characterizes long COVID due to the fragility of their vasculature and slow wound healing |
Jeffrey Lubell |
| 7 |
[GO] |
2023―Dec―09 |
Circulating Von Willebrand factor: a consistent biomarker predicting in-hospital mortality across different waves of the COVID-19 pandemic |
David M. Smadja, Anne-Sophie Jannot, Aurélien Philippe, Estelle Lu, Jeanne Rancic, Olivier Sanchez, Richard Chocron, Nicolas Gendron, Jean-Luc Diehl |
| 8 |
[GO] |
2023―Sep―02 |
Reply to “Embracing imatinib: a novel approach to safeguarding the endothelial barrier in patients with COVID-19” |
Xiaoming Wu, Jialan Shi |
| 9 |
[GO] |
2023―Aug―02 |
Embracing Imatinib: a novel approach to safeguarding the endothelial barrier in patients with COVID-19 |
Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan |
| 10 |
[GO] |
2023―Aug―01 |
VEGF-A plasma levels are associated with impaired DLCO and radiological sequelae in long COVID patients |
Aurélien Philippe, Sven Günther, Jeanne Rancic, Pauline Cavagna, Bertrand Renaud, Nicolas Gendron, Elie Mousseaux, Thông Hua-Huy, Guillaume Reverdito, Benjamin Planquette, Olivier Sanchez, Pascale Gaussem, Dominique Salmon, Jean-Luc Diehl, David M. Smadja |
| 11 |
[GO] |
2023―Apr―27 |
Damage to endothelial barriers and its contribution to long COVID |
Xiaoming Wu, Mengqi Xiang, Haijiao Jing, Chengyue Wang, Valerie A. Novakovic, Jialan Shi |
| 12 |
[GO] |
2022―Nov―12 |
Inflammation and vascular remodeling in COVID-19 hearts |
Christopher Werlein, Maximilian Ackermann, Helge Stark, Harshit R. Shah, Alexandar Tzankov, Jasmin Dinonne Haslbauer, Saskia von Stillfried, Roman David Bülow, Ali El-Armouche, Stephan Kuenzel, Jan Lukas Robertus, Marius Reichardt, Axel Haverich, Anne Höfer, Lavinia Neubert, Edith Plucinski, Peter Braubach, Stijn Verleden, Tim Salditt, Nikolaus Marx, Tobias Welte, Johann Bauersachs, Hans-Heinrich Kreipe, Steven J. Mentzer, Peter Boor, Stephen M. Black, Florian Länger, Mark Kuehnel, Danny Jonigk |
| 13 |
[GO] |
2022―Aug―11 |
Persistent capillary rarefication in long COVID syndrome |
Irina Osiaevi, Arik Schulze, Georg Evers, Kimon Harmening, Hans Vink, Philipp Kümpers, Michael Mohr, Alexandros Rovas |
| 14 |
[GO] |
2022―Jun―20 |
Microvascular and proteomic signatures overlap in COVID-19 and bacterial sepsis: the MICROCODE study |
Alexandros Rovas, Konrad Buscher, Irina Osiaevi, Carolin Christina Drost, Jan Sackarnd, Phil-Robin Tepasse, Manfred Fobker, Joachim Kühn, Stephan Braune, Ulrich Göbel, Gerold Thölking, Andreas Gröschel, Jan Rossaint, Hans Vink, Alexander Lukasz, Hermann Pavenstädt, Philipp Kümpers |
| 15 |
[GO] |
2021―Oct―29 |
Interferon-alpha or -beta facilitates SARS-CoV-2 pulmonary vascular infection by inducing ACE2 |
Timothy Klouda, Yuan Hao, Hyunbum Kim, Jiwon Kim, Judith Olejnik, Adam J. Hume, Sowntharya Ayyappan, Xuechong Hong, Juan Melero-Martin, Yinshan Fang, Qiong Wang, Xiaobo Zhou, Elke Mühlberger, Hongpeng Jia, Robert F. Padera, Benjamin A. Raby, Ke Yuan |
| 16 |
[GO] |
2021―Jun―28 |
COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects |
David M. Smadja, Steven J. Mentzer, Michaela Fontenay, Mike A. Laffan, Maximilian Ackermann, Julie Helms, Danny Jonigk, Richard Chocron, Gerald B. Pier, Nicolas Gendron, Stephanie Pons, Jean-Luc Diehl, Coert Margadant, Coralie Guerin, Elisabeth J. M. Huijbers, Aurélien Philippe, Nicolas Chapuis, Patrycja Nowak-Sliwinska, Christian Karagiannidis, Olivier Sanchez, Philipp Kümpers, David Skurnik, Anna M. Randi, Arjan W. Griffioen |
| 17 |
[GO] |
2021―Jun―08 |
Letter in response to: circulating von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortality |
P. Bhogal, G. Paul, G. Collins, O. Jaffer |
| 18 |
[GO] |
2021―May―11 |
Von Willebrand factor collagen-binding capacity predicts in-hospital mortality in COVID-19 patients: insight from VWF/ADAMTS13 ratio imbalance |
Aurélien Philippe, Nicolas Gendron, Olivier Bory, Agathe Beauvais, Tristan Mirault, Benjamin Planquette, Olivier Sanchez, Jean-Luc Diehl, Richard Chocron, David M. Smadja |
| 19 |
[GO] |
2021―Mar―23 |
Circulating level of Angiopoietin-2 is associated with acute kidney injury in coronavirus disease 2019 (COVID-19) |
Brandon Michael Henry, Maria Helena Santos de Oliveira, Isaac Cheruiyot, Justin L. Benoit, David S. Cooper, Giuseppe Lippi, Timothy D. Le Cras, Stefanie W. Benoit |
| 20 |
[GO] |
2021―Jan―15 |
Circulating Von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortality |
Aurélien Philippe, Richard Chocron, Nicolas Gendron, Olivier Bory, Agathe Beauvais, Nicolas Peron, Lina Khider, Coralie L. Guerin, Guillaume Goudot, Françoise Levasseur, Christophe Peronino, Jerome Duchemin, Julie Brichet, Elise Sourdeau, Florence Desvard, Sébastien Bertil, Frédéric Pene, Cherifa Cheurfa, Tali-Anne Szwebel, Benjamin Planquette, Nadia Rivet, Georges Jourdi, Caroline Hauw-Berlemont, Bertrand Hermann, Pascale Gaussem, Tristan Mirault, Benjamin Terrier, Olivier Sanchez, Jean-Luc Diehl, Michaela Fontenay, David M. Smadja |
| 21 |
[GO] |
2020―Oct―14 |
Angiogenesis, hereditary hemorrhagic telangiectasia and COVID-19 |
Antoni Riera-Mestre, Adriana Iriarte, Manuela Moreno, Raul del Castillo, Daniel López-Wolf |
| 22 |
[GO] |
2020―Oct―14 |
Microvascular dysfunction in COVID-19: the MYSTIC study |
Alexandros Rovas, Irina Osiaevi, Konrad Buscher, Jan Sackarnd, Phil-Robin Tepasse, Manfred Fobker, Joachim Kühn, Stephan Braune, Ulrich Göbel, Gerold Thölking, Andreas Gröschel, Hermann Pavenstädt, Hans Vink, Philipp Kümpers |
| 23 |
[GO] |
2020―May―27 |
Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients |
David M. Smadja, Coralie L. Guerin, Richard Chocron, Nader Yatim, Jeremy Boussier, Nicolas Gendron, Lina Khider, Jérôme Hadjadj, Guillaume Goudot, Benjamin Debuc, Philippe Juvin, Caroline Hauw-Berlemont, Jean-Loup Augy, Nicolas Peron, Emmanuel Messas, Benjamin Planquette, Olivier Sanchez, Bruno Charbit, Pascale Gaussem, Darragh Duffy, Benjamin Terrier, Tristan Mirault, Jean-Luc Diehl |
|
